Notable Labs Total Non-Operating Income/Expense 2013-2024 | NTBLQ

Notable Labs total non-operating income/expense from 2013 to 2024. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
Notable Labs Annual Total Non-Operating Income/Expense
(Millions of US $)
2023 $3
2022 $-1
2021 $0
2020 $0
2019 $1
2018 $1
2017 $1
2016 $0
2015 $-0
2014 $-3
2013 $-1
2012 $0
Notable Labs Quarterly Total Non-Operating Income/Expense
(Millions of US $)
2024-06-30 $0
2024-03-31 $0
2023-12-31 $5
2023-09-30 $-0
2023-06-30 $-0
2023-03-31 $-1
2022-12-31 $-2
2022-09-30 $0
2022-06-30 $0
2022-03-31 $0
2021-12-31 $0
2021-09-30 $0
2021-06-30 $-0
2021-03-31 $0
2020-12-31 $-0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31 $0
2019-09-30 $0
2019-06-30 $0
2019-03-31 $0
2018-12-31 $0
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $0
2017-09-30 $-0
2017-06-30 $0
2017-03-31 $0
2016-12-31 $0
2016-09-30 $0
2016-06-30 $0
2016-03-31 $0
2015-12-31 $0
2015-09-30 $-0
2015-06-30 $0
2015-03-31 $-0
2014-12-31 $-0
2014-09-30 $-0
2014-06-30 $-0
2014-03-31 $-2
2013-12-31
2013-09-30
2012-12-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.000B $0.000B
Notable Labs Ltd. is a clinical-stage platform therapeutics company developing predictive precision medicines for patients with cancer. Notable Labs Ltd., formerly known as Vascular Biogenics Ltd., is based in FOSTER CITY, Calif.
Stock Name Country Market Cap PE Ratio
Fanhua (AIFU) China $0.086B 2.07
Top KingWin (WAI) China $0.008B 0.00
S&W Seed (SANW) United States $0.006B 0.00
Invo BioScience (NAYA) United States $0.004B 0.00
Ocuphire Pharma (IRD) $0.000B 0.00